Home › Funds › DME Capital Management, LP › NUVB
DME Capital Management, LP position in NUVB
NUVATION BIO INC · Health Care
DME Capital Management, LP reported holding 34,995 shares of NUVB (NUVATION BIO INC) in its Q2 2026 13F filing — a position valued at US$199K, representing 0.01% of its reported portfolio and ranking #46 among its reported holdings. DME Capital Management, LP has disclosed NUVB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DME Capital Management, LP's NUVB position evolved
DME Capital Management, LP first disclosed a stake in NUVB in Q1 2024 at 34,995 shares (US$127K). The position peaked in Q4 2025 at 34,995 shares, worth US$314K. Across 10 filings, DME Capital Management, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 34,995 shares valued at US$199K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 34.99K | $127.38K | New |
| Q2 2024 | 34.99K | $102.19K | Hold |
| Q3 2024 | 34.99K | $80.14K | Hold |
| Q4 2024 | 34.99K | $93.09K | Hold |
| Q1 2025 | 34.99K | $61.59K | Hold |
| Q2 2025 | 34.99K | $68.24K | Hold |
| Q3 2025 | 34.99K | $129.48K | Hold |
| Q4 2025 | 34.99K | $313.56K | Hold |
| Q1 2026 | 34.99K | $150.13K | Hold |
| Q2 2026 | 34.99K | $198.77K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.82M sh · $44.42M · Q2 2026
- Context Capital Management, LLC 30.00M sh · $31.29M · Q2 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
- TANAKA CAPITAL MANAGEMENT INC 901.83K sh · $3.87M · Q1 2026
More on DME Capital Management, LP
FAQ
How long has DME Capital Management, LP held NUVB?
DME Capital Management, LP has disclosed NUVB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is DME Capital Management, LP's current position in NUVB?
As of Q2 2026, DME Capital Management, LP holds 34.99K shares of NUVB (NUVATION BIO INC), valued at $198.77K, representing 0.01% of its reported portfolio and ranking #46.
Has DME Capital Management, LP been buying or selling NUVB?
In the latest 13F filing (Q2 2026), DME Capital Management, LP held unchanged its position in NUVB. The position peaked in Q4 2025 at 34.99K shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.